Fifth Third Bancorp Dexcom Inc Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Dexcom Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 25,794 shares of DXCM stock, worth $1.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,794

Previous 27,341 5.66%

Holding current value

$1.96 Million

Previous $3.1 Million 44.24%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$64.0 - $116.06 $99,008 - $179,544	-1,547 Reduced 5.66%	25,794 $1.73 Million
Q2 2024 Jul 22, 2024	SELL	$110.31 - $140.45 $360,051 - $458,428	-3,264 Reduced 10.66%	27,341 $3.1 Million
Q1 2024 Apr 23, 2024	BUY	$114.22 - $140.1 $591,202 - $725,157	5,176 Added 20.35%	30,605 $4.24 Million
Q4 2023 Jan 19, 2024	BUY	$75.49 - $124.16 $218,468 - $359,319	2,894 Added 12.84%	25,429 $3.16 Million
Q3 2023 Oct 31, 2023	SELL	$86.06 - $137.93 $60,328 - $96,688	-701 Reduced 3.02%	22,535 $2.1 Million
Q2 2023 Jul 25, 2023	BUY	$112.47 - $130.98 $787,514 - $917,121	7,002 Added 43.13%	23,236 $2.99 Million
Q1 2023 Apr 24, 2023	SELL	$104.0 - $122.92 $34,736 - $41,055	-334 Reduced 2.02%	16,234 $1.89 Million
Q4 2022 Jan 25, 2023	BUY	$84.98 - $122.67 $106,225 - $153,337	1,250 Added 8.16%	16,568 $0
Q3 2022 Oct 25, 2022	BUY	$76.35 - $94.18 $156,746 - $193,351	2,053 Added 15.48%	15,318 $1.23 Million
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $661,066 - $1.29 Million	9,723 Added 274.51%	13,265 $989,000
Q1 2022 Apr 19, 2022	SELL	$94.08 - $130.2 $104,240 - $144,261	-1,108 Reduced 23.83%	3,542 $1.81 Million
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $240,389 - $301,379	1,851 Added 66.13%	4,650 $2.5 Million
Q3 2021 Oct 15, 2021	BUY	$106.71 - $143.18 $41,723 - $55,983	391 Added 16.24%	2,799 $1.53 Million
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $21,057 - $28,061	260 Added 12.1%	2,408 $1.03 Million
Q1 2021 May 07, 2021	BUY	$84.79 - $104.74 $56,046 - $69,233	661 Added 44.45%	2,148 $772,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $3,432 - $4,598	44 Added 3.05%	1,487 $550,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $6,208 - $7,341	65 Added 4.72%	1,443 $595,000
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $6,079 - $10,217	97 Added 7.57%	1,378 $559,000
Q1 2020 May 05, 2020	BUY	$47.79 - $75.63 $13,333 - $21,100	279 Added 27.84%	1,281 $345,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $878 - $1,374	24 Added 2.45%	1,002 $219,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $4,974 - $6,132	140 Added 16.71%	978 $146,000
Q2 2019 Aug 07, 2019	BUY	$27.84 - $38.92 $5,707 - $7,978	205 Added 32.39%	838 $126,000
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $17,768 - $24,167	633 New	633 $75,000
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $2,930 - $4,896	-258 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	258	258 $19,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Dexcom Inc Transaction History